Alternatively, we demonstrated that the injection of CXCL13 induced TLS formation accompanied by the inhibition of tumor growth in mouse models, and that CD4+ T cells were the major source of CXCL13 in human ovarian cancer TLS. This evidence concerns the gene CD4 and ovarian cancer.